{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:34:28Z","timestamp":1764794068009,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P023754\/1","MR\/N006631\/1"],"award-info":[{"award-number":["MR\/P023754\/1","MR\/N006631\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.coph.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T23:38:22Z","timestamp":1531006702000},"page":"16-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Advanced cellular systems to study tuberculosis treatment"],"prefix":"10.1016","volume":"42","author":[{"given":"Magdalena K","family":"Bielecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Elkington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.06.005_bib0005","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S1473-3099(16)00070-0","article-title":"Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers","volume":"16","author":"Wallis","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2018.06.005_bib0010","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1016\/j.bmcl.2013.07.006","article-title":"A medicinal chemists\u2019 guide to the unique difficulties of lead optimization for tuberculosis","volume":"23","author":"Dartois","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coph.2018.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJMe1410977","article-title":"Shortening treatment for tuberculosis\u2014to basics","volume":"371","author":"Warner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2018.06.005_bib0020","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"Via","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.coph.2018.06.005_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","article-title":"Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies","volume":"38","author":"Kramnik","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coph.2018.06.005_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2013.00098","article-title":"Modeling the Mycobacterium tuberculosis granuloma \u2013 the critical battlefield in host immunity and disease","volume":"4","author":"Guirado","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2018.06.005_bib0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkw421","article-title":"Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model","volume":"72","author":"Dalton","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2018.06.005_bib0040","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2174\/1568026617666170130111324","article-title":"Model systems for pulmonary infectious diseases: paradigms of anthrax and tuberculosis","volume":"17","author":"Arora","year":"2017","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.coph.2018.06.005_bib0045","doi-asserted-by":"crossref","first-page":"e02266-17","DOI":"10.1128\/AAC.02266-17","article-title":"Extreme drug tolerance of Mycobacterium tuberculosis in caseum","volume":"62","author":"Sarathy","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.06.005_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses","volume":"264","author":"Lenaerts","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2018.06.005_bib0055","first-page":"1","article-title":"Mechanisms of pyrazinamide action and resistance","volume":"2","author":"Zhang","year":"2013","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.coph.2018.06.005_bib0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/infdis\/jiv076","article-title":"The extracellular matrix regulates granuloma necrosis in tuberculosis","volume":"212","author":"Al Shammari","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2018.06.005_bib0065","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/acs.chemrev.7b00602","article-title":"Hit generation in TB drug discovery: from genome to granuloma","volume":"118","author":"Yuan","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.coph.2018.06.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence","volume":"4","author":"Peyron","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2018.06.005_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1462-5822.2004.00371.x","article-title":"An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells","volume":"6","author":"Puissegur","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.coph.2018.06.005_bib0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coph.2018.06.005_sbref0085","doi-asserted-by":"crossref","first-page":"e02537","DOI":"10.1128\/mBio.02537-14","article-title":"Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model","volume":"6","author":"Guirado","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.coph.2018.06.005_sbref0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1165\/rcmb.2016-0321OC","article-title":"A novel in vitro human granuloma model of sarcoidosis and latent tuberculosis infection","volume":"57","author":"Crouser","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2018.06.005_bib0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nm.4073","article-title":"Inflammatory signaling in human tuberculosis granulomas is spatially organized","volume":"22","author":"Marakalala","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2018.06.005_sbref0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053657","article-title":"Human granuloma in vitro model, for TB dormancy and resuscitation","volume":"8","author":"Kapoor","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2018.06.005_bib0105","first-page":"e53084","article-title":"A 3D human lung tissue model for functional studies on Mycobacterium tuberculosis infection","volume":"104","author":"Braian","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.coph.2018.06.005_sbref0110","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.3389\/fmicb.2017.02370","article-title":"Inhibition of tissue matrix metalloproteinases interferes with mycobacterium tuberculosis-induced granuloma formation and reduces bacterial load in a human lung tissue model","volume":"8","author":"Parasa","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coph.2018.06.005_bib0115","first-page":"281","article-title":"Modeling Mycobacterium tuberculosis early granuloma formation in experimental human lung tissue","volume":"7","author":"Parasa","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.coph.2018.06.005_bib0120","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.vaccine.2018.02.044","article-title":"Evaluation of the immunogenic capability of the BCG strains BCGDeltaBCG1419c and BCGDeltaBCG1416c in a three-dimensional human lung tissue model","volume":"36","author":"Parasa","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.coph.2018.06.005_bib0125","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.drudis.2017.05.005","article-title":"Host-directed therapies offer novel opportunities for the fight against tuberculosis","volume":"22","author":"Machelart","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2018.06.005_sbref0130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.03705-14","article-title":"High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis","volume":"59","author":"Silva-Miranda","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2018.06.005_sbref0135","doi-asserted-by":"crossref","first-page":"E2172","DOI":"10.1073\/pnas.1600812113","article-title":"Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model","volume":"113","author":"Silva","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2018.06.005_bib0140","doi-asserted-by":"crossref","first-page":"14183","DOI":"10.1038\/ncomms14183","article-title":"Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2018.06.005_bib0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","article-title":"Three-dimensional cell culture: the missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2018.06.005_bib0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40259-017-0258-x","article-title":"Applications of bioengineered 3D tissue and tumor organoids in drug development and precision medicine: current and future","volume":"32","author":"Devarasetty","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.coph.2018.06.005_sbref0155","doi-asserted-by":"crossref","first-page":"e02073-16","DOI":"10.1128\/mBio.02073-16","article-title":"A bioengineered three-dimensional cell culture platform integrated with microfluidics to address antimicrobial resistance in tuberculosis","volume":"8","author":"Bielecka","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coph.2018.06.005_sbref0160","doi-asserted-by":"crossref","first-page":"e21283","DOI":"10.7554\/eLife.21283","article-title":"Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model","volume":"6","author":"Tezera","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.coph.2018.06.005_bib0165","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/adfm.201303891","article-title":"Controlled generation of microspheres incorporating extracellular matrix fibrils for three-dimensional cell culture","volume":"24","author":"Workman","year":"2014","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.coph.2018.06.005_bib0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cix231","article-title":"Matrix degradation in human immunodeficiency virus type 1-associated tuberculosis and tuberculosis immune reconstitution inflammatory syndrome: a prospective observational study","volume":"65","author":"Walker","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2018.06.005_bib0175","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.201700067","article-title":"Thoughts on scaffolds","volume":"1","author":"Jayasinghe","year":"2017","journal-title":"Adv Biosyst"},{"issue":"Suppl 1","key":"10.1016\/j.coph.2018.06.005_bib0180","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/civ425","article-title":"Systematic analysis of hollow fiber model of tuberculosis experiments","volume":"61","author":"Pasipanodya","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2018.06.005_sbref0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ebiom.2016.02.040","article-title":"A long-term co-perfused disseminated tuberculosis-3D liver hollow fiber model for both drug efficacy and hepatotoxicity in babies","volume":"6","author":"Srivastava","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2018.06.005_bib0190","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coph.2018.06.005_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006421","article-title":"Experimental study of tuberculosis: from animal models to complex cell systems and organoids","volume":"13","author":"Fonseca","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2018.06.005_bib0200","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1242\/dev.140103","article-title":"Lung organoids: current uses and future promise","volume":"144","author":"Barkauskas","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.coph.2018.06.005_bib0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/adt.2015.647","article-title":"Drug discovery goes three-dimensional: goodbye to flat high-throughput screening?","volume":"13","author":"Eglen","year":"2015","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.coph.2018.06.005_bib0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fphar.2016.00334","article-title":"Drug discovery via human-derived stem cell organoids","volume":"7","author":"Liu","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2018.06.005_bib0215","doi-asserted-by":"crossref","first-page":"18889","DOI":"10.1038\/srep18889","article-title":"Drug response in organoids generated from frozen primary tumor tissues","volume":"6","author":"Walsh","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2018.06.005_sbref0220","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncb3510","article-title":"A three-dimensional model of human lung development and disease from pluripotent stem cells","volume":"19","author":"Chen","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.coph.2018.06.005_bib0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrd4539","article-title":"Organs-on-chips at the frontiers of drug discovery","volume":"14","author":"Esch","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2018.06.005_bib0230","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrd3799","article-title":"Revisiting lab-on-a-chip technology for drug discovery","volume":"11","author":"Neuzi","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2018.06.005_bib0235","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2013.137","article-title":"Microfabrication of human organs-on-chips","volume":"8","author":"Huh","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.coph.2018.06.005_bib0240","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.coph.2018.06.005_sbref0245","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1513\/AnnalsATS.201410-442MG","article-title":"A human breathing lung-on-a-chip","volume":"12","author":"Huh","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.coph.2018.06.005_sbref0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nmeth.3697","article-title":"Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro","volume":"13","author":"Benam","year":"2016","journal-title":"Nat Methods"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:48:55Z","timestamp":1761461335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217301595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":50,"alternative-id":["S1471489217301595"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.06.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"type":"print","value":"1471-4892"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced cellular systems to study tuberculosis treatment","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}